Significance, epidemiology, and prevention of peritoneal dialysis catheter infections

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Burkart, John M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Exit site infections; Nasal carriers; Staphylococcus aureus prevention

Indexed keywords

ANTIBIOTIC AGENT; PSEUDOMONIC ACID;

CATHETER INFECTION; CONFERENCE PAPER; HUMAN; INTRANASAL DRUG ADMINISTRATION; KIDNEY FAILURE; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WOUND CARE;

EID: 0029895885     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s66     Document Type: Conference Paper

References (38)

1. Lindblad AS, Hamilton RW, Novak JW. Complications of peritoneal catheters. In: Lindblad AS, Novak JW, Nolph KD, eds. Continuous ambulatory peritoneal dialysis in the USA - Final Report of the National CAPD Registry. Dordrecht: Kluwer Academic, 1989:157.
2. Gokal R, Ash SR, Helfrich B,et al. Peritoneal catheters and exit site practices: toward optimum peritoneal access. Perit Dial Int 1993; 13:29-39.
3. Bernardini J, Holley JL, Johnston JR, et al. An analysis of ten-year trends in infections in adults on CAPD. Clin Nephrol 1991; 36:29-34.
4. Pierratos A. Peritoneal dialysis glossary. Perit Dial Bull 1984; 4:2.
5. Luzar MA, Brown C, Balf D, et al. Exit-site care and exit-site infection in CAPD: results of a randomized multicenter trial. Perit Dial Int 1990; 10:25-9.
6. Piraino B, Bernardini J, Sorkin M. A five-year study of microbiologic results of exit-site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10:281.
7. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505.
8. Vogt K, Binswanger U, Buchmann P, et al. Catheterrelated complications during continuous ambulatory peritoneal dialysis (CAPD): a retrospective study on sixty-two double cuff Tenckhoff catheters. Am J Kidney Dis 1987; 10:47.
9. Piraino B, Bernardini J, Sorkin M. Catheter infections as a factor in the transfer of CAPD patients to hemodialysis. Am J Kidney Dis 1989; 13:365.
10. Twardowski ZJ. Peritoneal dialysis catheter exit site infections: prevention, diagnosis, treatment, and future directions. Semin Dial 1992; 5:305-15.
11. Krizek TJ, Robson MC. Biology of surgical infection. Surg Clin North Am 1975; 55:1261.
12. Twardowski ZJ, Dobbie JW, Moore HL, et al. Morphology of peritoneal dialysis catheter tunnel: macroscopy and light microscopy. Perit Dial Int 1991; 11:237-51.
13. Twardowski ZJ. Exit site infection. In: La Greca G, Ronco C, Feriani M, Chiaramonte F, Conz P, eds. Peritoneal dialysis: proceedings of the fourth international course on peritoneal dialysis, Vincenza, Italy, 1991. Milano: Wichtig Editore, 1991:241-5.
14. Twardowski ZJ, Prowant BF, Khanna R, et al. Longterm experience with Swan neck Missouri catheters. ASAIO Trans 1991; 37:M491-4.
15. Twardowski ZJ, Prowant BF, Nichols WK, et al. Sixyear experience with Swan neck catheters. Perit Dial Int 1992; 12:384-9.
16. Dasgupta MK. Silver peritoneal catheters reduce bacterial colonization. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6:195-8.
17. Kahl AA, Grosse-Siestrup C, Kahl KA, et al. Reduction of exit site infections in peritoneal dialysis by local application of metallic silver: a preliminary report. Perit Dial Int 1994; 14:177-80.
18. Moncrief J, Popovich R, Seare W, et al. Reduction of exit site infection rates in peritoneal dialysis via an innovative spatially specific porous material (Abstract). Perit Dial Int 1995; 15(Suppl):S21.
19. Burkart JM, Jordan JR, Durnell TA,et al. Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial Int 1992; 12:317-20.
20. Piraino B, Bernardini J, Sorkin MI. Bagless CAPD improves catheter infection rates. Kidney Int 1988; 35:275.
21. Piraino B, Bernardini J, Sorkin MI. The effect of the Y-set on catheter infection rates in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1990; 16:46.
22. Ash SA, Nichols WK. Placement, repair, and removal of chronic peritoneal catheters. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994:315-33.
23. Moncrief JW, Popovich RP, Dasgupta M, et al. Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis with a new catheter and implantation technique. Perit Dial Int 1993; 13(Suppl):S329.
24. Read RR, Dasgupta MK, Parker E, et al. Peritonitis in peritoneal dialysis: bacterial colonization by biofilm along the catheter surface. Kidney Int 1989; 35:614.
25. Prowant BF, Warady BA, Nolph KD. Peritoneal dialysis catheter exit site care: results of an international survey. Perit Dial Int 1993; 13:149.
26. Prowant BF, Schmidt LM, Twardowski ZJ, et al. Peritoneal dialysis catheter exit site care. Am Nephrol Nurs Assoc J 1988; 15:219.
27. Fuchs J, Gallagher ME, Jackson Bey D, et al. A prospective randomized study of peritoneal catheter exit site care. Dial Transplant 1990; 19:81.
28. White A, Smith J. Nasal reservoir as the source of extranasal staphylococci. Antimicrob Agents Chemother 1963; 3:679.
29. Sewell CM, Clarridge J, Lacke C,et al. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982; 248:1493.
30. Sesso R, Draibe S, Castelo A, et al. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1989; 31:264.
31. Davies SJ, Ogg CS, Cameron JS, et al. Staphylococcus aureus nasal carriage, exit site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9:61.
32. Piraino B, Perlmutter JA, Holley JL, et al. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl):S332.
33. Pignatari A, Pfaller M, Hollis R, et al. Methicillinresistant Staphylococcal infection in patients on continuous ambulatory peritoneal dalysis. J Clin Microbiol 1990; 28:1898.
34. Brown AL, Stephenson JE, Baker LR, et al. Epidemiology of CAPD-associated peritonitis caused by coagulase-negative staphylococci: comparison of strains isolated from hands, abdominal Tenckhoff catheter site and peritoneal fluid. Nephrol Dial Transplant 1991; 50:643.
35. Twardowski ZJ, Prowant BF. Staphylococcus aureus nasal carriage is not associated with an increased incidence of exit-site infection with the same organism. Pent Dial Int 1993; 13(Suppl):S306.
36. Swartz R, Messana J, Starmann B, et al. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991; 2:1085.
37. Zimmerman SW, Ahrens E, Johnson CA, et al. Randomized controlled trials of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18:225.
38. Coles GA (Mupirocin Study Group). The effect of intranasal mupirocin on CAPD exit site infections. (Abstract) J Am Soc Nephrol 1994; 5:439.